13F
← All fund report cards

GRIMES & COMPANY, INC.

13F equity value
$3.6B
Positions
433
Top 10 concentration
44.0%
Quarters / total new picks
32 / 372
13F equity value over time
$0M$2B$4B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.0% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 53.1% of quarters (excess t = 0.52, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+1.0%
t-stat
0.52
Quarterly win rate
53%
Annualized excess
+1.0%
$1 → follow vs universe
$2.25 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.02120180630: follow 0.98920180930: follow 1.05520181231: follow 0.78720190331: follow 0.75720190630: follow 0.79720190930: follow 0.87620191231: follow 0.78220200331: follow 0.87520200630: follow 0.96320200930: follow 1.22020201231: follow 1.39120210331: follow 1.41020210630: follow 1.56620210930: follow 1.48120211231: follow 1.32720220331: follow 1.44120220630: follow 1.46320220930: follow 1.40920221231: follow 1.36920230331: follow 1.49120230630: follow 1.54020230930: follow 1.67020231231: follow 1.71720240331: follow 1.75620240630: follow 1.96520240930: follow 1.92420241231: follow 1.90720250331: follow 2.03020250630: follow 2.09320250930: follow 2.19020251231: follow 2.245 0.70 1.56 2.42 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 433 · 2026 Q1

Ticker Value Weight QoQ
IEFA $324M
9.0%
HOLD
VB $299M
8.3%
ADD
IEMG $176M
4.9%
HOLD
SJNK $172M
4.8%
HOLD
IVV $159M
4.4%
TRIM
JHML $122M
3.4%
HOLD
AAPL $108M
3.0%
HOLD
XLK $96M
2.7%
TRIM
XLC $71M
2.0%
ADD
MSFT $65M
1.8%
HOLD
NVDA $60M
1.7%
ADD
VUG $52M
1.4%
HOLD
RSP $48M
1.3%
ADD
XLV $46M
1.3%
TRIM
TSM $45M
1.3%
TRIM
GOOGL $38M
1.1%
TRIM
PRF $36M
1.0%
HOLD
AMZN $36M
1.0%
ADD
AVLC $34M
0.9%
ADD
JNJ $29M
0.8%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.